Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:BACKNASDAQ:BTTXOTCMKTS:GENNNYSE:UPHL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeBACKIMAC$0.04-9.3%$0.04$0.03▼$3.49$83K2.09439,399 shs5,507 shsBTTXBetter Therapeutics$0.00$0.00$0.00▼$0.03$5K1.1919,107 shs203,110 shsGENNGenesis Healthcare$0.00$0.00$0.00▼$0.30$33K-2.554,908 shs2,318 shsUPHLUpHealth$0.00$0.00$0.00▼$0.55$4K0.858,312 shs3,003 shs10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceBACKIMAC+19.84%+33.64%+21.49%-92.01%-98.45%BTTXBetter Therapeutics0.00%0.00%-50.00%-50.00%-99.09%GENNGenesis Healthcare0.00%0.00%0.00%0.00%-81.82%UPHLUpHealth0.00%-33.33%0.00%0.00%-99.96%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationBACKIMACN/AN/AN/AN/AN/AN/AN/AN/ABTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AGENNGenesis HealthcareN/AN/AN/AN/AN/AN/AN/AN/AUPHLUpHealthN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceBACKIMAC 0.00N/AN/AN/ABTTXBetter Therapeutics 0.00N/AN/AN/AGENNGenesis Healthcare 0.00N/AN/AN/AUPHLUpHealth 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookBACKIMAC$72.05K1.15N/AN/A($0.66) per share-0.06BTTXBetter TherapeuticsN/AN/AN/AN/AN/AN/AGENNGenesis HealthcareN/AN/AN/AN/AN/AN/AUPHLUpHealth$130M0.00N/AN/A$3.10 per share0.00Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateBACKIMAC-$9.42MN/A0.00∞N/AN/AN/A-325.44%8/4/2025 (Estimated)BTTXBetter Therapeutics-$39.76MN/A0.00∞N/AN/AN/AN/A6/3/2025 (Estimated)GENNGenesis HealthcareN/AN/A0.00∞N/AN/AN/AN/AN/AUPHLUpHealth-$56.42M-$1.35N/A∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthBACKIMACN/AN/AN/AN/AN/ABTTXBetter TherapeuticsN/AN/AN/AN/AN/AGENNGenesis Healthcare$0.1260,000.00%N/AN/AN/AUPHLUpHealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioBACKIMACN/A0.080.08BTTXBetter TherapeuticsN/AN/AN/AGENNGenesis HealthcareN/AN/AN/AUPHLUpHealthN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipBACKIMAC5.84%BTTXBetter Therapeutics34.00%GENNGenesis HealthcareN/AUPHLUpHealth56.10%Insider OwnershipCompanyInsider OwnershipBACKIMAC12.26%BTTXBetter Therapeutics51.40%GENNGenesis Healthcare36.59%UPHLUpHealth34.24%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableBACKIMAC1802.07 million1.82 millionNot OptionableBTTXBetter Therapeutics4049.86 million24.23 millionOptionableGENNGenesis Healthcare47,000164.80 millionN/ANot OptionableUPHLUpHealth1,75018.93 million12.45 millionNo DataGENN, BACK, UPHL, and BTTX HeadlinesRecent News About These CompaniesUpHealth, Inc. (UPHL) Latest Stock News & Headlines - Yahoo FinanceApril 24, 2025 | finance.yahoo.comLemon Dump Cake RecipeSeptember 9, 2024 | msn.comDJUSIV Dow Jones US Business Support Services IndexJuly 27, 2024 | seekingalpha.comUpHealth Inc Ordinary Shares UPHLJuly 19, 2024 | morningstar.comUpHealth Holdings, Inc. Wins Ruling in Calcutta High Court, Mandating All Glocal Healthcare Respondents Submit Affidavits of AssetsMay 24, 2024 | prnewswire.comUpHealth, Inc. (UPHL) Advances While Market Declines: Some Information for InvestorsApril 30, 2024 | zacks.comUpHealth, Inc. (UPHL)April 17, 2024 | finance.yahoo.comCalcutta High Court rules in favour of UpHealth Holdings, Inc., and vigorously reinforces the ICC International Court of Arbitration previous $110 million award against Glocal directors and other Respondents, calling their conduct “dishonest and fraudulent”April 16, 2024 | finance.yahoo.comUpHealth Holdings Takes Steps to Enforce the International Court of Arbitration’s Final Award to UpHealth Holdings of more than $110 Million in Damages in Breach of Contract Lawsuit Involving the 2020 Purchase by UpHealth of Glocal Healthcare SystemsApril 1, 2024 | finance.yahoo.comUpHealth, Inc.: UpHealth Provides Corporate Update and Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 22, 2024 | finanznachrichten.deUpHealth Provides Corporate Update and Announces Fourth Quarter and Full Year 2023 Financial ResultsMarch 21, 2024 | finance.yahoo.comHealthcare Triangle GAAP EPS of -$1.26, revenue of $7.1MMarch 18, 2024 | msn.comMedia Sentiment Over TimeTop HeadlinesView All HeadlinesWhy Wells Fargo Is Buying $40 Billion of Its Own StockBy Gabriel Osorio-Mazilli | May 6, 2025View Why Wells Fargo Is Buying $40 Billion of Its Own StockD-Wave Pushes Back on Short Seller Case With Strong EarningsBy Nathan Reiff | May 14, 2025View D-Wave Pushes Back on Short Seller Case With Strong EarningsNVIDIA-Backed CoreWeave Jumps 28%: Is It The Next Great AI Buy?By Leo Miller | May 20, 2025View NVIDIA-Backed CoreWeave Jumps 28%: Is It The Next Great AI Buy?Buybacks and Big-Time Developments: 3 Stocks Making Huge MovesBy Leo Miller | May 19, 2025View Buybacks and Big-Time Developments: 3 Stocks Making Huge MovesUber Stock Ready to Ride Higher on Waymo PartnershipBy Gabriel Osorio-Mazilli | May 28, 2025View Uber Stock Ready to Ride Higher on Waymo PartnershipGENN, BACK, UPHL, and BTTX Company DescriptionsIMAC NASDAQ:BACK$0.04 0.00 (-9.30%) As of 12:25 PM EasternIMAC Holdings, Inc. owns and manages innovative medical advancements and care regeneration centers, and backspace clinics in the United States. The company's outpatient medical clinics provide regenerative, orthopedic, and minimally invasive procedures and therapies to patients with sports injuries, ligament and tendon damage, and other related soft tissue conditions, as well as back, knee, and joint pains. It also provides medical treatments, regenerative, spinal decompression, chiropractic manipulation, and physical medicine and therapy. IMAC Holdings, Inc. was founded in 2000 and is headquartered in Franklin, Tennessee.Better Therapeutics NASDAQ:BTTX$0.0001 0.00 (0.00%) As of 06/2/2025 10:57 AM EasternBetter Therapeutics, Inc., a prescription digital therapeutics company, develops a form of cognitive behavioral therapy to address the causes of cardiometabolic diseases. The company's lead product candidate is BT-001, an investigational PDT platform to treat type 2 diabetes. It also develops software-based prescription digital therapeutics platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions. In addition, the company's clinical development candidates are intended to treat cardiometabolic diseases, including type 2 diabetes, hypertension, hyperlipidemia, non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and chronic kidney disease. Its product pipeline also includes BT-002, which intends glycemic control for hypertension; BT-003 to reduce LDL cholesterol in patients with hyperlipidemia; and BT-004, which intends to explore the impact of treatment on liver health in patients with non-alcoholic steatohepatitis/non-alcoholic fatty liver disease. The company was founded in 2015 and is headquartered in San Francisco, California.Genesis Healthcare OTCMKTS:GENN$0.0002 0.00 (0.00%) As of 02:18 PM EasternGenesis Healthcare, Inc., together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services; Rehabilitation Therapy Services; and Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy. In addition, the company offers other specialty medical services, such as physician, staffing, and other healthcare related services. As of December 31, 2020, it provided inpatient services through a network of approximately 341 skilled nursing facilities and assisted/senior living communities in 24 states; and supplied rehabilitation and respiratory therapy to approximately 1,400 healthcare locations in 42 states, the District of Columbia and China. The company was formerly known as FC-GEN Operations Investment, LLC and changed its name to Genesis HealthCare, Inc. in February 2015. Genesis HealthCare, Inc. was founded in 2003 and is headquartered in Kennett Square, Pennsylvania.UpHealth NYSE:UPHL$0.0002 0.00 (0.00%) As of 11:27 AM EasternUpHealth, Inc. provides behavioral health solutions through the utilization of evidence-based treatments and services in the Americas. The company offers mental health and substance use disorder treatment services directly to consumers. It also provides detoxification, residential, partial hospitalization program, intensive outpatient program, outpatient services, and non-clinical recovery residence and supporting housing services. UpHealth, Inc. is headquartered in Delray Beach, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 3 Reasons Amazon Could Be the Best Tech Performer in June Ollie’s Q1 Earnings: The Good, the Bad, and What’s Next Applied Digital: CoreWeave’s AI Deal Lights a $7 Billion Fuse Qualcomm: A Technical Deep-Dive Confirms the Worst Rocket Lab Expands Into Payloads: Should You Be Paying Attention? Steel Dynamics Shares Climb After Tariff Announcement Palantir Soars on Government Deals as Valuation Debate Lingers Broadcom Earnings Preview: AVGO Stock Near Record Highs Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
